VeriMommonascus extract est-il sûr pendant la grossesse ?
Monascus extracts commonly contain monacolin K, which EFSA and other assessments treat as identical to lovastatin; statins have documented developmental/embryofetal concerns in animal studies and are clinically contraindicated or advised against in pregnancy—this supports a suspected reproductive hazard (h=2). The mechanism (HMG‑CoA reductase inhibition altering cholesterol biosynthesis needed for fetal development) is demonstrated (m=2). Topical cosmetic exposure is likely low but measurable (e=1). Sources: EFSA/scientific opinion on monacolins, FDA/statin pregnancy communications, and statin pregnancy reviews.
Alternatives sûres à monascus extract pendant la grossesse | VeriMom
Related ingredients
Frequently asked questions
- monascus extract est-il sûr pendant la grossesse ?
- Monascus extracts commonly contain monacolin K, which EFSA and other assessments treat as identical to lovastatin; statins have documented developmental/embryofetal concerns in animal studies and are clinically contraindicated or advised against in pregnancy—this supports a suspected reproductive hazard (h=2). The mechanism (HMG‑CoA reductase inhibition altering cholesterol biosynthesis needed for fetal development) is demonstrated (m=2). Topical cosmetic exposure is likely low but measurable (e=1). Sources: EFSA/scientific opinion on monacolins, FDA/statin pregnancy communications, and statin pregnancy reviews.
- monascus extract est-il sûr pendant l'allaitement ?
- Because monacolin K = lovastatin and statins have been advised against in breastfeeding (potential for infant exposure and drug effects), the same suspected hazard (h=2) and demonstrated mechanism (m=2) apply. Topical absorption from cosmetics is expected to be low but measurable (e=1). Clinical/regulatory guidance recommends avoiding statins in breastfeeding. Sources: FDA statements and clinical reviews.
- monascus extract est-il sûr pour la peau de bébé ?
- Do not increase hazard or mechanism absent infant‑specific toxicology, but exposure (e) is increased by +1 for infants due to immature skin barrier/higher surface‑area‑to‑weight. Thus e=2 when an extract contains absorbable monacolin K. Additionally, contamination risk with citrinin (a nephrotoxic mycotoxin) in some Monascus products is relevant for infant safety.
- Comment VeriMom évalue-t-il monascus extract ?
- VeriMom évalue monascus extract à 40/100 (risque moyen) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à monascus extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à monascus extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.